Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $9.98
- 52-wk high
- $20.46
- High
- $10.08
- 52-wk low
- $7.21
- Low
- $9.70
- Prev close
- $10.05
Smart money
Earnings
Earnings landed in line with what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $134.2M | $139.2M | $114.5M | $124.4M |
| Cost of what it sold | $58.6M | $50.3M | $33.7M | $38.1M |
| Gross profit | $75.6M | $88.8M | $80.8M | $86.3M |
| What it spent | ||||
| Research and development | $1.5M | $1.4M | $2.6M | $6.0M |
| Sales and admin | $21.8M | $23.5M | $26.7M | $26.7M |
| Other operating costs | $1.3M | $1.2M | $1.1M | $1.1M |
| Total operating expenses | $24.6M | $26.1M | $30.4M | $33.8M |
| What was left | ||||
| Operating profit | $51.0M | $62.8M | $50.3M | $52.4M |
| Interest on debt | $1.7M | $1.6M | $2.1M | $3.4M |
| Profit before tax | $47.5M | $61.6M | $57.1M | $50.2M |
| Tax | $11.1M | $12.2M | $11.8M | $12.4M |
| Net profit | $36.4M | $49.4M | $45.3M | $37.8M |
| EBITDA | $51.2M | $65.3M | $61.1M | $57.3M |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
75 / 100
RSI 14
20D volatility
52-week range
20D support
News
What the news says
Coverage is bearish
Tone of tracked coverage
Law firm probes ADMA Biologics' leadership for possible breaches of fiduciary duty
NeutralAug 18ADMA BIOLOGICS, INC. (ADMA) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
BearishAug 18Bank of America Corp DE Raises Holdings in ADMA Biologics Inc $ADMA
Leans bullish